POZESCAF

PozeSCAF Inc

@immunocureds

Brooklyn, NY
https://www.pozescaf.com/
Biotechnology Research

Overview

About PozeSCAF Inc

Transforming Drug Discovery through AxDrug & Synthesis Expertise AxDrug, our state-of-the-art AI engine, revolutionizes the drug discovery landscape by swiftly identifying promising "hit" molecules with unparalleled accuracy. At PozeSCAF, we don't stop at identification. With our in-house chemistry lab, we design, synthesize, and deliver molecules to our clients, analyzing assay results and progressing to the Lead optimization stage. Global Reach, Local Excellence While headquartered in the USA, our scientific team and lab in India ensure cutting-edge solutions at competitive rates, facilitating a seamless R&D journey without financial strain. Our Core Values, Your Guaranteed Success At PozeSCAF, our partnership is built on a foundation of innovation, integrity, commitment, trust, transparency, accountability, loyalty, and respect. With unwavering dedication, we ensure your success becomes our own. Unleashing Knowledge Beyond the Molecular Level Deep insights into molecular interactions at the atomic level, powered by computational methods, unlock unprecedented potential. Through machine learning tools, we transform data into actionable knowledge, empowering us in drug discovery from hit identification to lead optimization and beyond. AxDrug: Pioneering Your R&D Voyage AxDrug, our proprietary AI platform, seamlessly orchestrates the entire R&D process—from hit identification to lead optimization and deployment—with unparalleled efficiency and automation. Forge Ahead with the AI-Powered Trailblazers Beyond mere service providers, we are your trusted research partner. Join us on a transformative discovery journey fueled by AI and human ingenuity. Together, let's unlock the future of medicine.

Headquarters

Brooklyn, NY

Website

https://www.pozescaf.com/

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2026

Specialties

small molecule discovery, AI, machine learning, molecular modeling, predictive toxicology, custom AI model, artificial intelligence, deep learning, de novo drug design, predictive modelling, QSAR studies, virtual screening, peptide screening, molecular dynamic simulations, computational peptide design, computational drug discovery, molecular docking, hit to lead, in silico, hit identification, lead optimisation, IND enabling studies, integrated drug discovery, and target validation